tas-114

Small moleculeexperimental

Clinical trial activity

4 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Jun 1, 2012 (NCT01610479)

Timeline

2010s

  1. Jan 1, 2012

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2016

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • tas-114
  • tas-114

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02855125Phase 2Aug 1, 2016Otsuka
NCT02454062Phase 1Mar 1, 2013Otsuka
NCT02025803Phase 1Nov 1, 2012IQVIA, Otsuka
NCT01610479Phase 1Jun 1, 2012Otsuka
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
OtsukaFor profit4422012
IQVIAFor profit1012012
2 organizations
Page 1 / 1